IV Iron Therapy and Anemia Management in Patients on Hemodialysis: Benefits of a Revised CQI Strategy

IV Iron Therapy and Anemia Management in Patients on Hemodialysis: Benefits of a Revised CQI Strategy


Identification: nnj_ja08A3
Issue: July-August 2008
Volume: Vol. 35, No. 4

Standard: $30.00

Description

This article is available to members for free.

Goal: To illustrate how the successive use of a continuous quality improvement program for maintaining and improving an intravenous iron and anemia management protocol can improve patient outcomes.

Objectives:

  1. Describe the revision of an anemia management protocol in the context of an established CQI process.
  2. Explain how evidence-based literature on erythropoietin-stimulating agents and IV iron therapy should be used to drive CQI revision.
  3. Evaluate the effects on patient outcomes of a revised anemia management protocol using the CQI process.


Acknowledgments: The author acknowledges the assistance of David S. MacDougall and Liz Turrin in the preparation of this manuscript. Writing assistance was provided with support from Watson.

Disclosure Statement: The author reported that she is on the Watson Pharmaceuticals Speakers' Bureau.

Note: This article is supported by a financial grant from Watson Pharma, Inc. This article has undergone peer review. The information in this article does not necessarily reflect the opinions of ANNA or the sponsor.

Author(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content